ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer

Publication date: November 2019Source: Journal of the American College of Radiology, Volume 16, Issue 11, SupplementAuthor(s): Expert Panel on Urological Imaging, Andrei S. Purysko, Paul Nikolaidis, Vikram S. Dogra, Dhakshinamoorthy Ganeshan, John L. Gore, Rajan T. Gupta, Marta E. Heilbrun, Gaurav Khatri, Amar U. Kishan, Andrej Lyshchik, Stephen J. Savage, Andrew D. Smith, Zhen J. Wang, Darcy J. Wolfman, Jade J. Wong-You-Cheong, Don C. Yoo, Mark E. LockhartAbstractRenal cell carcinoma (RCC) accounts for most malignant renal tumors and is considered the most lethal of all urologic cancers. For follow-up of patients with treated or untreated RCC and those with neoplasms suspected to represent RCC, radiologic imaging is the most useful component of surveillance, as most relapses and cases of disease progression are identified when patients are asymptomatic. Understanding the strengths and limitations of the various imaging modalities for the detection of disease, recurrence, or progression is important when planning follow-up regimens. This publication addresses the appropriate imaging examinations for asymptomatic patients who have been treated for RCC with radical or partial nephrectomy, or ablative therapies. It also discusses the appropriate imaging examinations for asymptomatic patients with localized biopsy-proven or suspected RCC undergoing active surveillance.The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical co...
Source: Journal of the American College of Radiology - Category: Radiology Source Type: research